EUVIMEDEUVIMED entdecken
Übersichtsarbeit

lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression

Raihan Siddique, Lakshmi Thangavelu, RenukaJyothi S, Waleed Hassan Almalki, Imran Kazmi, Ashwani Kumar, Shriya Mahajan, Hitesh Kalra, Sami I Alzarea, Kumud Pant

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155333 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Raihan Siddique und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India. Hauptthemen laut MEDLINE: Neoplasms, RNA, Long Noncoding, Cyclin-Dependent Kinases, Disease Progression. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 156 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long non-coding RNAs (lncRNAs) are a diverse class of RNA molecules that do not code for proteins but play critical roles in gene regulation. One such role involves the modulation of cell cycle progression and proliferation through interactions with cyclin-dependent kinases (CDKs), key regulators of cell division. Dysregulation of CDK activity is a hallmark of cancer, contributing to uncontrolled cell growth and tumor formation. These lncRNA-CDK interactions are part of a complex network of molecular mechanisms underlying cancer pathogenesis, involving various signaling pathways and regulatory circuits. Understanding the interplay between lncRNAs, CDKs, and cancer biology holds promise for developing novel therapeutic strategies targeting these molecular targets for more effective cancer treatment. Furthermore, targeting CDKs, key cell cycle progression and proliferation regulators, offers another avenue for disrupting cancer pathways and overcoming drug resistance. This can open new possibilities for individualized treatment plans and focused therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRNA, Long NoncodingCyclin-Dependent KinasesDisease ProgressionHumansGene Expression Regulation, NeoplasticAnimalsSignal TransductionCell ProliferationCell Cycle

Stichwörter der Autor:innen

CDKs pathwayCancerLong non-coding RNAMolecular mechanism

Substanzen

RNA, Long NoncodingCyclin-Dependent Kinases

Autor:innen und Institutionen

  • School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India.
  • Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, India. Electronic address: drlakshmi.thangavelu25@gmail.com.
  • Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
  • Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Biochemistry, Faculty of Science, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
  • Department of Pharmacy, Vivekananda Global University, Jaipur, Rajasthan 303012, India.

Zitieren

APA

Siddique, R., Thangavelu, L., S, R., Almalki, W. H., Kazmi, I., Kumar, A., Mahajan, S., Kalra, H., Alzarea, S. I., & Pant, K. (2024). lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155333

Vancouver

Siddique R, Thangavelu L, S R, Almalki WH, Kazmi I, Kumar A, et al. lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155333

BibTeX
@article{Siddique2024,
  author = {Siddique, Raihan and Thangavelu, Lakshmi and S, RenukaJyothi and Almalki, Waleed Hassan and Kazmi, Imran and Kumar, Ashwani and Mahajan, Shriya and Kalra, Hitesh and Alzarea, Sami I and Pant, Kumud},
  title = {lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155333}
}
Kostenlos starten →